title: Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
authors.forename: Y
authors.initials: Y
authors.lastname: Agid
authors.forename: A
authors.initials: A
authors.lastname: Destée
authors.forename: F
authors.initials: F
authors.lastname: Durif
authors.forename: J L
authors.initials: JL
authors.lastname: Montastruc
authors.forename: P
authors.initials: P
authors.lastname: Pollak
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001577:Benzophenones / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009596:Nitrophenols; D010300:Parkinson Disease / Q000188:drug therapy*; D000077867:Tolcapone
chemical_list: D000978:Antiparkinson Agents; D001577:Benzophenones; D009596:Nitrophenols; D001971:Bromocriptine; D007980:Levodopa; D000077867:Tolcapone